CytomX Therapeutics (CTMX) Tax Rate Growth (1y) (2016 - 2026)
CytomX Therapeutics (CTMX) Tax Rate Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn |
| 10 | CytomX Therapeutics | 598.30 Mn | 251.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.00 |
| Dec 31, 2025 | 1,397.00 |
| Sep 30, 2025 | -146.00 |
| Jun 30, 2025 | -6,844.00 |
| Mar 31, 2025 | -9.00 |
| Dec 31, 2024 | -5,576.00 |
| Sep 30, 2024 | -4,749.00 |
| Dec 31, 2020 | -62.00 |
| Mar 31, 2020 | 31,583.00 |
| Dec 31, 2019 | 3,879.00 |
| Mar 31, 2019 | 767.00 |
| Dec 31, 2018 | 47,664.00 |
| Sep 30, 2018 | -1,213.00 |
| Jun 30, 2018 | -1,526.00 |
| Mar 31, 2018 | -764.00 |
| Dec 31, 2017 | -51,504.00 |
| Sep 30, 2017 | 19.00 |
| Jun 30, 2017 | -8.00 |
| Mar 31, 2017 | 3.00 |
| Dec 31, 2016 | 20.00 |